Trading SMID Biotech Stocks in a Volatile Market…Update-2 7/6
Update- 7/6...The XBI model works as expected-if the XBI has momentum the chances are very good your SMID biotech stock will rally. The following stocks show gains or minimal losses over the past year. Stocks showing trading gains are : ADPT, CRSP, GERN, NTRA, RNA, TWST, VCEL. Update-1...
Healthcare and Biotech Investing: Breakthroughs in the Treatment of Cancer at ASCO…Update-4….6/29-MRK!
Update-4...6/29....I'm back but I did not miss much in biotech trades, but a lot of "3 day wonders'" you know stocks that get momentum then quickly fade. The XBI is still holding above the $90 support level with a range of $89.13 to $94.88 closing Friday at $92.71 so nimble traders could have...
Large Cap Biopharmaceuticals: Updates on #ASCO24 Week…Update-2
Update-2 Biopharma rally moves to SMID caps as momentum picks up ADPT, NVAX, TWST etc XBI over $93. Large caps steady with REGN over $1000. POST ASCO large cap core portfolio picks: ABBV, AZN, LLY, MRK, REGN. VRTX. Pfizer had good results but the stock could not break $30 so my calls with...
Life Science Momentum Trades In a Volatile Market…Update-6…..Many big winners
Update: 6/7/24.,,Our model still looks good for experienced traders.Today for example GERON (GERN) soared 19% with approval of RYTELO for MDS associated anemia. We will summarize news from winning stocks over the weekend. XBI was weak today down about 1% to $91 handle. Strong jobs could mean...
Large Cap Biopharmaceuticals Performance…Update-3 #ASCO24 gains are ahead
UPDATE 3: Large cap biopharmas were strong on Friday in anticipation of #ASCO24 data. Company news to watch from data below:AZN, BMY, GILD, LLY, MRK, PFE,REGN and also ADPT, MRUS, NVS. REPL.. See updates all next week. Update-2 MAY 31,,,Biopharma stocks took a dip midweek during FED speak then...